HCA Healthcare Inc (NYSE: HCA) is 43.53% higher on its value in year-to-date trading and has touched a low of $215.96 and a high of $388.82 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HCA stock was last observed hovering at around $388.78 in the last trading session, with the day’s loss setting it -0.28%.
Currently trading at $388.50, the stock is 6.07% and 12.70% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing -0.07% at the moment leaves the stock 25.25% off its SMA200. HCA registered 42.52% gain for a year compared to 6-month gain of 24.04%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.50% loss in the last 1 month and extending the period to 3 months gives it a 21.90%, and is 3.82% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.22% over the week and 1.84% over the month.
HCA Healthcare Inc (HCA) has around 310000 employees, a market worth around $100.26B and $68.35B in sales. Current P/E ratio is 18.23 and Fwd P/E is 15.74. Profit margin for the company is 8.40%. Distance from 52-week low is 79.89% and -0.08% from its 52-week high. The company has generated returns on investments over the last 12 months (15.68%).
with sales reaching $17.53B over the same period.The EPS is expected to grow by 17.27% this year, but quarterly earnings will post 9.20% year-over-year. Quarterly sales are estimated to grow 8.10% in year-over-year returns.
HCA Healthcare Inc (HCA) Top Institutional Holders
1595.0 institutions hold shares in HCA Healthcare Inc (HCA), with institutional investors hold 89.51% of the company’s shares. The shares outstanding are 265.54M, and float is at 185.65M with Short Float at 1.38%. Institutions hold 64.55% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.84 million shares valued at $5.41 billion. The investor’s holdings represent 6.3976% of the HCA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.85 million shares valued at $4.77 billion to account for 5.6425 of the shares outstanding. The other top investors are SANDERS CAPITAL, LLC which holds 11.52 million shares representing 4.3769% and valued at over $3.7 billion, while WELLINGTON MANAGEMENT GROUP LLP holds 4.0955 of the shares totaling 10.78 million with a market value of $3.46 billion.
HCA Healthcare Inc (HCA) Insider Activity
The most recent transaction is an insider sale by Whalen Kathleen M, the company’s SVP & Chief Ethics Officer. SEC filings show that Whalen Kathleen M sold 2,987 shares of the company’s common stock on Jul 31 ’24 at a price of $363.51 per share for a total of $1.09 million. Following the sale, the insider now owns 9454.0 shares.
HCA Healthcare Inc disclosed in a document filed with the SEC on Jul 29 ’24 that Whalen Kathleen M (SVP & Chief Ethics Officer) sold a total of 1,864 shares of the company’s common stock. The trade occurred on Jul 29 ’24 and was made at $359.92 per share for $0.67 million. Following the transaction, the insider now directly holds 12441.0 shares of the HCA stock.
Still, SEC filings show that on Jul 29 ’24, Reiner Deborah M (SVP – Mktg. & Communications) disposed off 3,314 shares at an average price of $359.96 for $1.19 million. The insider now directly holds 3,510 shares of HCA Healthcare Inc (HCA).
